Refractive Surgery

>

Latest News

First patient enrolled in LYNX-2 Phase 3 study
First patient enrolled in LYNX-2 Phase 3 study

April 12th 2024

The LYNX-2 Phase 3 study is evaluating phentolamine ophthalmic solution 0.75% for the treatment of decreased visual acuity under low light conditions following keratorefractive surgery

FDA Approves TENEO Excimer Laser Platform from Bausch + Lomb
FDA Approves TENEO Excimer Laser Platform from Bausch + Lomb

January 8th 2024

FDA gives its blessing to Ocuphire Pharma’s special protocol assessment for LYNX-2 Phase 3 clinical trial
FDA gives its blessing to Ocuphire Pharma’s special protocol assessment for LYNX-2 Phase 3 clinical trial

January 4th 2024

Two-year results of laser scleral microporation
Two-year results of laser scleral microporation

November 16th 2023

(Adobe Stock / © Axel Kock)
AAO 2023: Spotlight on IOLs

November 1st 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.